Cheryl has over 25 years of experience in the pharmaceutical industry, including 20 years in leadership roles at organisations such as Novartis and AbbVie. She is the Chief Executive Officer at Starpharma, an Australian biotechnology company focused on developing innovative therapies using dendrimer technology to improve patients’ lives with unmet medical needs, such as cancer.
Her expertise includes leading pharmaceutical innovation, marketing strategies, and business growth across Australia, Asia, and international markets. While at Novartis, Cheryl held several senior leadership positions, including Country Head and President of Novartis Philippines and the General Manager of Oncology, Australia and New Zealand (ANZ). She has led large and smaller organisations, as well as cross-functional teams across multiple geographies.Â
Cheryl’s career journey embodies resilience, curiosity, and unwavering dedication to driving transformative change in healthcare and biotechnology leadership. She is a staunch advocate for helping others achieve their career goals through mentorship, leadership development programs and experiences, and is passionate about diversity and inclusion within the industry.